{"category":{"kind":"industry","slug":"life-sciences","name":"Life Sciences","tagline":null,"description":null,"synonyms":[],"target_queries":[],"added_via":"pr","added_at":"2026-09-04T03:50:13.532Z","updated_at":"2026-09-04T03:50:13.532Z","example":false,"profile_url":"/industries/life-sciences","is_stub":true,"member_count":33,"member_counts":{"accelerator":8,"company":25}},"members":[{"listing_type":"company","name":"Virelion Biotech","slug":"virelion-biotech","tagline":"Engineering The Heart","description":"Virelion Biotech is an early-stage biotechnology venture building computational and experimental infrastructure for cardiac regeneration, cardiovascular phenotyping, translational research, and biological decision support. Its modular research stack connects cardiac data and evidence, experimental design, biological measurement, machine learning, benchmarking, evaluation, simulation, provenance, and interoperability.","url":"https://virelionbiotech.netlify.app/","is_stealth":false,"normalized_domain":"virelionbiotech.netlify.app","normalized_url_key":"virelionbiotech.netlify.app","parent_slug":null,"parent":null,"type_data":{},"logo":null,"links":[{"label":"X / Twitter","url":"https://x.com/VirelionBiotech","platform":"x"},{"label":"LinkedIn","url":"https://www.linkedin.com/company/virelion/","platform":"linkedin"},{"label":"Instagram","url":"https://www.instagram.com/virelionbiotech/","platform":"instagram"}],"entry_points":[{"kind":"homepage","url":"https://virelionbiotech.netlify.app/","audience":"any","primary":false,"listed_by":"owner","derived_from":"url","on_listing_domain":true},{"kind":"github","url":"https://github.com/Virelion-Biotech","audience":"any","primary":false,"listed_by":"owner","derived_from":"github","on_listing_domain":false}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://virelionbiotech.netlify.app/","audience":"any","primary":false,"listed_by":"owner","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[{"person_slug":"syed-umer-hannan-3fblh9ry0wa0i","name":"Syed Umer Hannan","role":"CEO","bio":null,"location":null,"image_url":null,"image_asset_id":null,"links":[]}],"media":{"logo_asset_id":"afde59ab-e89b-41a3-a020-ef010a06040e","cover_asset_id":"84b21595-2a73-4f76-a4bb-4f91cb6ab830","screenshot_asset_ids":[]},"categories":["Biotech","Life Sciences","AI","Deep Tech","Healthcare","Biomedical Engineering","Research","Regenerative Medicine"],"stage":"pre-seed","founded_year":2024,"location":"United States","pricing":"Free","twitter":null,"github":"https://github.com/Virelion-Biotech","linkedin":null,"contact_email":"virelion85@gmail.com","added_at":"2026-09-23T15:12:56.531Z","added_via":"web","geo":null,"agents":null,"featured_until":null,"example":false,"ownership_status":"verified","claimed_by_agent_id":null,"claimed_via_claim_id":"cfd71606-484a-4cc6-9e3b-36d9903241bc","claimed_at":"2026-09-23T15:17:45.470Z","updated_at":"2026-09-23T15:17:45.470Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"ai","name":"AI","note":null,"profile_url":"/industries/ai"},{"kind":"industry","slug":"biomedical-engineering","name":"Biomedical Engineering","note":null,"profile_url":"/industries/biomedical-engineering"},{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"deep-tech","name":"Deep Tech","note":null,"profile_url":"/industries/deep-tech"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"life-sciences","name":"Life Sciences","note":null,"profile_url":"/industries/life-sciences"},{"kind":"industry","slug":"regenerative-medicine","name":"Regenerative Medicine","note":null,"profile_url":"/industries/regenerative-medicine"},{"kind":"industry","slug":"research","name":"Research","note":null,"profile_url":"/industries/research"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-23T15:12:56.531Z","updated_at":"2026-09-23T15:12:56.531Z"}},{"listing_type":"company","name":"bit.bio","slug":"bit-bio","tagline":"Human cell models reprogrammed from stem cells at scale","description":"bit.bio is a Cambridge, UK synthetic biology company whose opti-ox technology reprograms human stem cells into specific cell types precisely, consistently and at scale. Its ioCells human cell models are used in drug discovery, disease research, functional genomics and toxicology. In November 2026 bit.bio announced a $25 million Series D, with participation from existing investor M&G Investments, to expand its cell-model portfolio.","url":"https://www.bit.bio/","is_stealth":false,"normalized_domain":"bit.bio","normalized_url_key":"bit.bio","parent_slug":null,"parent":null,"type_data":{},"logo":"https://www.bit.bio/hs-fs/hubfs/Logos/bit.bio/bitbio-logotype-no_tagline-color-positive-RGB.png","links":[],"entry_points":[{"kind":"homepage","url":"https://www.bit.bio/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.bit.bio/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":{"logo_asset_id":"438c4ead-431d-4c7e-8cca-ec03e48597ae"},"categories":["Biotech","Synthetic Biology","Life Sciences"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":"https://www.linkedin.com/company/bitbioltd","contact_email":null,"added_at":"2026-11-05T13:24:00.900Z","added_via":"web","geo":null,"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-11-05T13:25:25.773Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"life-sciences","name":"Life Sciences","note":null,"profile_url":"/industries/life-sciences"},{"kind":"industry","slug":"synthetic-biology","name":"Synthetic Biology","note":null,"profile_url":"/industries/synthetic-biology"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-11-05T13:24:00.900Z","updated_at":"2026-11-05T13:24:00.900Z"}},{"listing_type":"company","name":"nPhase","slug":"nphase","tagline":"AI-native clinical data platform connecting trial data from capture to regulatory submission","description":"nPhase is a clinical research technology company based in Atlantic Beach, Florida. Its enterprise platform, nPhase.ai, unifies a Unified Data Management System (UDMS) and a Statistical Computing Environment (SCE) to connect the clinical data lifecycle from study startup through regulatory submission for pharmaceutical sponsors and CROs, with continuous data ingestion, near-real-time validation and AI agents working under human oversight. It also offers REDCap Cloud, an EDC platform for small and mid-size sponsors, academic and nonprofit research, MedTech and real-world data programs. In November 2026 nPhase closed a $30 million Series D led by Viking Global Investors, its first equity raise since 2017.","url":"https://www.nphase.ai/","is_stealth":false,"normalized_domain":"nphase.ai","normalized_url_key":"nphase.ai","parent_slug":null,"parent":null,"type_data":{},"logo":"https://cdn.prod.website-files.com/6a0b6ffff037c9a0a56521fe/6a22ecaa823f5d4db6aa3519_nPhase_Logo_Icon_Black.png","links":[],"entry_points":[{"kind":"homepage","url":"https://www.nphase.ai/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.nphase.ai/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":{"logo_asset_id":"f0b2a5c3-7ec1-41f6-b3ff-929c9eb026ac"},"categories":["Clinical Trials","Health Tech","Life Sciences"],"stage":null,"founded_year":null,"location":"Atlantic Beach, Florida, USA","pricing":null,"twitter":null,"github":null,"linkedin":"https://www.linkedin.com/company/nphase-ai","contact_email":null,"added_at":"2026-11-03T16:18:35.379Z","added_via":"web","geo":null,"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-11-03T16:19:19.187Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"clinical-trials","name":"Clinical Trials","note":null,"profile_url":"/industries/clinical-trials"},{"kind":"industry","slug":"health-tech","name":"Health Tech","note":null,"profile_url":"/industries/health-tech"},{"kind":"industry","slug":"life-sciences","name":"Life Sciences","note":null,"profile_url":"/industries/life-sciences"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-11-03T16:18:35.379Z","updated_at":"2026-11-03T16:18:35.379Z"}},{"listing_type":"company","name":"Vitroscope","slug":"vitroscope","tagline":"Perfusion platforms that keep living human tissue and organoids viable for real-time drug discovery research","description":"Vitroscope is a Norwegian biotech company based in Trondheim that develops perfusion platforms for studying immune activity, treatment responses and disease mechanisms in living human tissue. Its benchtop system, vitro.alive, combines programmable perfusion, real-time control of oxygen, pH and temperature, and live-cell imaging in a well-plate footprint with six independent channels, and works with standard inverted microscopes and a browser-based experiment interface. A higher-throughput platform, vitro.scale, is planned for launch in 2028. In November 2026 Vitroscope raised $7 million: a $5 million seed round co-led by Cerberus Ventures and YZR Capital plus $2 million in non-dilutive funding from the Research Council of Norway.","url":"https://www.vitroscope.com/","is_stealth":false,"normalized_domain":"vitroscope.com","normalized_url_key":"vitroscope.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://www.vitroscope.com/vitroscope_logo.png","links":[],"entry_points":[{"kind":"homepage","url":"https://www.vitroscope.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.vitroscope.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":{"logo_asset_id":"bc361c22-ac1b-4523-a8e0-079b4e5ce1b5"},"categories":["Biotech","Life Sciences","Drug Discovery"],"stage":null,"founded_year":null,"location":"Trondheim, Norway","pricing":null,"twitter":null,"github":null,"linkedin":"https://www.linkedin.com/company/vitroscope/","contact_email":null,"added_at":"2026-11-03T13:19:14.180Z","added_via":"web","geo":null,"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-11-03T13:22:45.809Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"drug-discovery","name":"Drug discovery","note":null,"profile_url":"/industries/drug-discovery"},{"kind":"industry","slug":"life-sciences","name":"Life Sciences","note":null,"profile_url":"/industries/life-sciences"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-11-03T13:19:14.180Z","updated_at":"2026-11-03T13:19:14.180Z"}},{"listing_type":"company","name":"Safer Human Medicine","slug":"safer-human-medicine","tagline":"Building a domestic US supply of specific-pathogen-free research primates for biomedical research","description":"Safer Human Medicine (SHM) is a US company that supplies specific-pathogen-free (SPF) non-human primates, including macaques, for biomedical and preclinical research, aiming to provide a sustainable domestic supply amid the US research primate shortage. Its services include client-owned breeding colonies and importation and quarantine coordination, with an emphasis on animal-welfare standards. It is backed by 8VC.","url":"https://saferhm.com/","is_stealth":false,"normalized_domain":"saferhm.com","normalized_url_key":"saferhm.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://saferhm.com/wp-content/uploads/2025/06/Primary-Logo.png","links":[],"entry_points":[{"kind":"homepage","url":"https://saferhm.com/","audience":"human","primary":true,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://saferhm.com/","audience":"human","primary":true,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":{"logo_asset_id":"bcc33a1c-fdbb-4566-805c-9b4c16620cee"},"categories":["Biotech","Life Sciences","Research Services"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":"https://www.linkedin.com/company/safer-human-medicine/","contact_email":null,"added_at":"2026-10-29T01:20:36.083Z","added_via":"web","geo":null,"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-10-29T01:21:57.007Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"life-sciences","name":"Life Sciences","note":null,"profile_url":"/industries/life-sciences"},{"kind":"industry","slug":"research-services","name":"Research Services","note":null,"profile_url":"/industries/research-services"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-10-29T01:20:36.083Z","updated_at":"2026-10-29T01:20:36.083Z"}},{"listing_type":"company","name":"Samplix","slug":"samplix","tagline":"Droplet microfluidics for functional single-cell analysis","description":"Samplix is a Danish biotech company headquartered in Birkerød, founded in 2013, that develops droplet microfluidics technology for high-throughput, function-first single-cell analysis. Its Xdrop platform encapsulates living cells and assay reagents in double-emulsion droplets compatible with standard flow cytometry and cell sorting, used in antibody discovery, immunotherapy and cell line development. In October 2026 it announced a EUR 25 million first close of a financing round led by WLanholding GmbH.","url":"https://samplix.com/","is_stealth":false,"normalized_domain":"samplix.com","normalized_url_key":"samplix.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://samplix.com/files/$images/Samplix_droplets_blue_RGB.png","links":[{"label":"YouTube","url":"https://www.youtube.com/@samplix4497"},{"label":"Financing announcement (EU-Startups)","url":"https://www.eu-startups.com/2026/10/danish-biotech-samplix-secures-e25-million-in-first-close-of-financing-round-to-scale-antibody-discovery/"}],"entry_points":[{"kind":"homepage","url":"https://samplix.com/","audience":"human","primary":true,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://samplix.com/","audience":"human","primary":true,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":{"logo_asset_id":"8115c26f-235f-4e7f-b883-e8979a2f6c9b"},"categories":["Biotech","Life Sciences","Drug Discovery"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":"https://www.linkedin.com/company/samplix-aps/","contact_email":null,"added_at":"2026-10-28T07:19:15.099Z","added_via":"web","geo":null,"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-10-28T07:21:08.886Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"drug-discovery","name":"Drug discovery","note":null,"profile_url":"/industries/drug-discovery"},{"kind":"industry","slug":"life-sciences","name":"Life Sciences","note":null,"profile_url":"/industries/life-sciences"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-10-28T07:19:15.099Z","updated_at":"2026-10-28T07:19:15.099Z"}},{"listing_type":"company","name":"Warp Sciences","slug":"warp-sciences","tagline":"U.S. chemistry CRO combining expert chemists, AI and robotics to make and test molecules for drug discovery","description":"Warp Sciences is a San Francisco company building a U.S.-based preclinical chemistry contract research organization (CRO) for biotech and pharma teams. It brings expert chemists, AI and robotics together to make and test the research compounds drug discovery teams need, in labs built for increasing automation so experimental data can train better scientific AI. Warp has no drug pipeline of its own. It was co-founded by Kevin Weil (CEO, formerly Chief Product Officer and VP of Science at OpenAI), DJ Patil (COO, first U.S. Chief Data Scientist), Sol Reisberg (CSO, medicinal chemist, co-founder of Terremoto Biosciences) and Manohar Paluri (CTO, FAIR co-founder and former VP at Meta Superintelligence Labs). On October 22, 2026 it emerged from stealth with $215 million in funding led by Lightspeed, with Premji Invest, Mayfield, IVP, Lux, Menlo Ventures and others participating.","url":"https://warp.xyz/","is_stealth":false,"normalized_domain":"warp.xyz","normalized_url_key":"warp.xyz","parent_slug":null,"parent":null,"type_data":{},"logo":"https://warp.xyz/apple-touch-icon.png","links":[{"label":"X","url":"https://x.com/warpsciences","platform":"x"},{"label":"Launch press release (Business Wire)","url":"https://www.businesswire.com/news/home/20261022200104/en/Warp-Sciences-Emerges-From-Stealth-With-%24215-Million-to-Build-U.S.-Chemistry-Services-for-Drug-Research"},{"label":"Why We're Backing Warp (Lightspeed)","url":"https://lsvp.com/stories/why-were-backing-warp/"}],"entry_points":[{"kind":"homepage","url":"https://warp.xyz/","audience":"human","primary":true,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://warp.xyz/","audience":"human","primary":true,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":{"logo_asset_id":"c19b5339-2e98-42fa-8ba9-4c7da477adf2"},"categories":["Biotech","AI","Robotics","Drug Discovery","Life Sciences"],"stage":"series-a","founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":"https://www.linkedin.com/company/warp-sciences/","contact_email":null,"added_at":"2026-10-23T16:20:26.140Z","added_via":"web","geo":null,"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-10-23T16:26:00.673Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"ai","name":"AI","note":null,"profile_url":"/industries/ai"},{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"drug-discovery","name":"Drug discovery","note":null,"profile_url":"/industries/drug-discovery"},{"kind":"industry","slug":"life-sciences","name":"Life Sciences","note":null,"profile_url":"/industries/life-sciences"},{"kind":"industry","slug":"robotics","name":"Robotics","note":null,"profile_url":"/industries/robotics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-10-23T16:20:26.140Z","updated_at":"2026-10-23T16:20:26.140Z"}},{"listing_type":"company","name":"Orchestra Bio","slug":"orchestra-bio","tagline":"Intelligent management platform helping biotech and pharma teams plan and run drug development","description":"Orchestra Bio built an intelligent management platform that helps research and development organizations unify planning, automate operations and reduce the risks that derail drug development programs across discovery, preclinical, manufacturing and clinical work. Founded about four years ago by Ashoka Rajendra, it announced on October 20, 2026 that it is joining OpenAI, where its platform will be combined with OpenAI's life sciences tools.","url":"https://orchestra.bio/","is_stealth":false,"normalized_domain":"orchestra.bio","normalized_url_key":"orchestra.bio","parent_slug":null,"parent":null,"type_data":{},"logo":"https://framerusercontent.com/images/o2qgMaiR03x0g2F2MJxQZR2UkAk.png","links":[{"label":"SiliconANGLE: OpenAI acquires Orchestra Bio","url":"https://siliconangle.com/2026/10/20/openai-acquires-orchestra-bio-to-bring-ai-agents-into-drug-development/"}],"entry_points":[{"kind":"homepage","url":"https://orchestra.bio/","audience":"human","primary":true,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://orchestra.bio/","audience":"human","primary":true,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":{"logo_asset_id":"ddfee7e7-5601-46fc-8115-d777523d1efe"},"categories":["Biotech","AI","Life Sciences","R&D Software"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-10-21T04:30:32.727Z","added_via":"web","geo":null,"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-10-21T04:30:49.055Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"ai","name":"AI","note":null,"profile_url":"/industries/ai"},{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"life-sciences","name":"Life Sciences","note":null,"profile_url":"/industries/life-sciences"},{"kind":"industry","slug":"r-and-d-software","name":"R&D Software","note":null,"profile_url":"/industries/r-and-d-software"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-10-21T04:30:32.727Z","updated_at":"2026-10-21T04:30:32.727Z"}},{"listing_type":"company","name":"Cellbox Solutions","slug":"cellbox-solutions","tagline":"Warm-chain logistics for living cells: transportable CO2 incubators and live-cell shipment services","description":"Cellbox Solutions is a German warm-chain logistics technology company that keeps living biological materials alive in transit. It combines transportable CO2 incubators (the Cellbox Go and Shipper lines for ground and air transport) with logistics services and workflow integration, maintaining physiological temperature and CO2 conditions for drug discovery, cell and gene therapy, clinical and IVF workflows. Founder and CEO Prof. Dr. Kathrin Adlkofer leads the company. In October 2026 EU-Startups reported Cellbox completed the final closing of its Series A at €5 million in total, with members of Baltic Business Angels Invest joining existing investors NRW.BANK and Fraunhofer Venture.","url":"https://cellbox-solutions.com/","is_stealth":false,"normalized_domain":"cellbox-solutions.com","normalized_url_key":"cellbox-solutions.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://cellbox-solutions.com/assets/img/icons/apple-icon-180x180.png","links":[{"label":"YouTube","url":"https://www.youtube.com/@cellboxsolutions","platform":"youtube"}],"entry_points":[{"kind":"homepage","url":"https://cellbox-solutions.com/","audience":"human","primary":true,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://cellbox-solutions.com/","audience":"human","primary":true,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":{"logo_asset_id":"204a4db3-f6ab-49e2-bdc9-21911c7e055b"},"categories":["Biotech","Life Sciences","Logistics","Hardware"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":"https://x.com/Cellbox_","github":null,"linkedin":"https://www.linkedin.com/company/cellbox-solutions/","contact_email":null,"added_at":"2026-10-20T19:28:05.131Z","added_via":"web","geo":null,"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-10-20T20:15:04.273Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"hardware","name":"Hardware","note":null,"profile_url":"/industries/hardware"},{"kind":"industry","slug":"life-sciences","name":"Life Sciences","note":null,"profile_url":"/industries/life-sciences"},{"kind":"industry","slug":"logistics","name":"Logistics","note":null,"profile_url":"/industries/logistics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-10-20T19:28:05.131Z","updated_at":"2026-10-20T19:28:05.131Z"}},{"listing_type":"company","name":"Radical Numerics","slug":"radical-numerics","tagline":"AI lab building toward general biological intelligence with Omnii-1, a multimodal genome language model","description":"Radical Numerics is a next-generation AI lab building toward general biological intelligence: AI that can interpret, generate and predict biology, with a dual mandate to advance biological intelligence and strengthen biodefense.","url":"https://www.radicalnumerics.ai/","is_stealth":false,"normalized_domain":"radicalnumerics.ai","normalized_url_key":"radicalnumerics.ai","parent_slug":null,"parent":null,"type_data":{},"logo":"https://cdn.sanity.io/images/0g0784cc/production/0e8bb7df8e06b1514a4a7f7a7067e11d09b72291-1200x630.png","links":[{"label":"YouTube","url":"https://www.youtube.com/@RadicalNumerics","platform":"youtube"}],"entry_points":[{"kind":"homepage","url":"https://www.radicalnumerics.ai/","audience":"human","primary":true,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.radicalnumerics.ai/","audience":"human","primary":true,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":{"logo_asset_id":"2d041997-e156-496f-ba7c-7f57912ade6b"},"categories":["AI","Biotech","Life Sciences"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":"https://x.com/RadicalNumerics","github":null,"linkedin":"https://www.linkedin.com/company/radical-numerics","contact_email":null,"added_at":"2026-10-20T19:53:13.993Z","added_via":"web","geo":null,"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-10-20T20:14:42.857Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"ai","name":"AI","note":null,"profile_url":"/industries/ai"},{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"life-sciences","name":"Life Sciences","note":null,"profile_url":"/industries/life-sciences"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-10-20T19:53:13.993Z","updated_at":"2026-10-20T19:53:13.993Z"}},{"listing_type":"company","name":"Nouscom","slug":"nouscom","tagline":"Clinical-stage biotech developing off-the-shelf neoantigen cancer immunotherapies","description":"Nouscom is a Basel-based clinical-stage biotech founded in 2015 that develops next-generation neoantigen-targeted immunotherapies, with a focus on cancer interception. Its lead programme NOUS-209 is an investigational off-the-shelf neoantigen-based immunotherapy for people with Lynch Syndrome. Marina Udier is CEO. In October 2026 it closed an oversubscribed 120 million euro Series D co-led by M Ventures and Revelation Partners, with new investors Angelini Ventures, the EIB and Neva SGR and existing investors including 5AM Ventures, Versant Ventures and EQT Life Sciences.","url":"https://nouscom.com/","is_stealth":false,"normalized_domain":"nouscom.com","normalized_url_key":"nouscom.com","parent_slug":null,"parent":null,"type_data":{},"logo":null,"links":[{"label":"Series D coverage (EU-Startups)","url":"https://www.eu-startups.com/2026/10/switzerlands-nouscom-bags-e120-million-to-bring-innovative-cancer-immunotherapy-closer-to-clinical-trials/","platform":"other"}],"entry_points":[{"kind":"homepage","url":"https://nouscom.com/","audience":"human","primary":true,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://nouscom.com/","audience":"human","primary":true,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Biotech","Oncology","Immunotherapy","Life Sciences"],"stage":"series-b+","founded_year":2015,"location":"Basel, Switzerland","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-10-19T10:41:55.498Z","added_via":"web","geo":null,"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-10-19T10:41:55.498Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"immunotherapy","name":"Immunotherapy","note":null,"profile_url":"/industries/immunotherapy"},{"kind":"industry","slug":"life-sciences","name":"Life Sciences","note":null,"profile_url":"/industries/life-sciences"},{"kind":"industry","slug":"oncology","name":"Oncology","note":null,"profile_url":"/industries/oncology"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-10-19T10:41:55.498Z","updated_at":"2026-10-19T10:41:55.498Z"}},{"listing_type":"company","name":"OMass Therapeutics","slug":"omass-therapeutics","tagline":"Oxford spin-out discovering small-molecule medicines with native mass spectrometry","description":"OMass Therapeutics is a UK biotech founded in 2016 as a spin-out from Professor Dame Carol Robinson's lab at the University of Oxford. Its OdyssION discovery platform combines native mass spectrometry, proprietary biochemistry and custom chemistry to study drug targets such as solute carriers and GPCRs within their native ecosystems. Its lead programme OMS1620, an MC2 receptor antagonist, is heading through Phase 2 development in congenital adrenal hyperplasia and ACTH-dependent Cushing's syndrome, with an SLC15A4 inhibitor for lupus following. In October 2026 it announced an oversubscribed €275 million (£230 million) Series C co-led by Bain Capital Life Sciences, Forbion and Novo Holdings. Ros Deegan is CEO.","url":"https://www.omass.com/","is_stealth":false,"normalized_domain":"omass.com","normalized_url_key":"omass.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://www.omass.com/app/uploads/2021/10/favicon-300x300.png","links":[{"label":"X / Twitter","url":"https://x.com/omasstx","platform":"x"},{"label":"LinkedIn","url":"https://www.linkedin.com/company/omass-therapeutics","platform":"linkedin"},{"label":"EU-Startups: €275M Series C","url":"https://www.eu-startups.com/2026/10/oxford-spin-out-omass-therapeutics-lands-e275-million-to-bring-novel-small-molecule-therapies-closer-to-patients/","platform":"other"}],"entry_points":[{"kind":"homepage","url":"https://www.omass.com/","audience":"human","primary":true,"listed_by":"community","on_listing_domain":true},{"kind":"other","url":"https://www.omass.com/news/","audience":"human","label":"News","primary":false,"listed_by":"community","on_listing_domain":true},{"kind":"other","url":"https://www.omass.com/pipeline/","audience":"human","label":"Pipeline","primary":false,"listed_by":"community","on_listing_domain":true},{"kind":"other","url":"https://www.omass.com/team/","audience":"human","label":"Team","primary":false,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.omass.com/","audience":"human","primary":true,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[{"name":"Carol Robinson","role":"Scientific founder","person_slug":"carol-robinson-07yzbvsji0wu7","bio":null,"location":null,"links":[]}],"media":{"logo_asset_id":"b9a04760-1747-4c4e-8190-121f6037aa47"},"categories":["Biotechnology","Drug Discovery","Life Sciences","Healthcare"],"stage":"series-b+","founded_year":2016,"location":"Oxford, United Kingdom","pricing":null,"twitter":"https://x.com/omasstx","github":null,"linkedin":"https://www.linkedin.com/company/omass-therapeutics","contact_email":null,"added_at":"2026-10-17T04:25:16.920Z","added_via":"web","geo":null,"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-10-17T04:25:16.920Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"biotechnology","name":"Biotechnology","note":null,"profile_url":"/industries/biotechnology"},{"kind":"industry","slug":"drug-discovery","name":"Drug discovery","note":null,"profile_url":"/industries/drug-discovery"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"life-sciences","name":"Life Sciences","note":null,"profile_url":"/industries/life-sciences"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-10-17T04:25:16.920Z","updated_at":"2026-10-17T04:25:16.920Z"}},{"listing_type":"company","name":"Silvia Bio","slug":"silvia-bio","tagline":"Cell profiling and precision media additives that boost biologic drug manufacturing yields","description":"Silvia Bio is a University of Sheffield spinout that helps biopharmaceutical companies make biologic drugs more efficiently. Its platform profiles how a customer's mammalian production cells (such as CHO cells) behave during manufacturing to pinpoint the processes limiting yield and quality, then supplies licensable small-molecule media additives that target those bottlenecks in the bioreactor. Founded in 2025 by CEO Ed Curry, Melinda Pohle and Sheffield academics Adam Brown and David James, building on more than 20 years of Sheffield biomanufacturing research. In October 2026 it raised £3M led by Northern Gritstone with Parkwalk, the UK Innovation & Science Seed Fund, Wren Capital and angels, to move into dedicated lab space in Sheffield and grow its team.","url":"https://www.silviabio.com/","is_stealth":false,"normalized_domain":"silviabio.com","normalized_url_key":"silviabio.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://cdn.prod.website-files.com/695d32600d39f8e780e16fff/695e4545bbfd44c4fbcf2d1f_Silvia%20Bio%20-%20Webclip.png","links":[{"label":"LinkedIn","url":"https://www.linkedin.com/company/silviabio/","platform":"linkedin"},{"label":"£3M round (TFN)","url":"https://techfundingnews.com/sheffield-spinout-silvia-bio-raises-3m-northern-gritstone-biomanufacturing/"}],"entry_points":[{"kind":"homepage","url":"https://www.silviabio.com/","audience":"human","primary":true,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.silviabio.com/","audience":"human","primary":true,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":{"logo_asset_id":"3f8d242d-6936-4f50-8b6c-a67d38c20a21"},"categories":["Biotech","Biomanufacturing","Life Sciences","B2B"],"stage":"seed","founded_year":2025,"location":"Sheffield, UK","pricing":null,"twitter":null,"github":null,"linkedin":"https://www.linkedin.com/company/silviabio/","contact_email":null,"added_at":"2026-10-15T13:34:26.382Z","added_via":"web","geo":null,"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-10-15T13:34:26.382Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"b2b","name":"B2B","note":null,"profile_url":"/industries/b2b"},{"kind":"industry","slug":"biomanufacturing","name":"Biomanufacturing","note":null,"profile_url":"/industries/biomanufacturing"},{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"life-sciences","name":"Life Sciences","note":null,"profile_url":"/industries/life-sciences"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-10-15T13:34:26.382Z","updated_at":"2026-10-15T13:34:26.382Z"}},{"listing_type":"company","name":"Intero Biosystems","slug":"intero-biosystems","tagline":"Miniature human organs for predictive preclinical drug testing","description":"Intero Biosystems builds complex iPSC-derived human organoids, miniature organs that let pharma companies test drug safety and efficacy on human biology before clinical trials, aiming to identify better medications and cut clinical trial costs. Its first model, GastroScreen, is a human miniature intestine. It was selected for the TechCrunch Disrupt 2026 Startup Battlefield Top 20.","url":"https://www.interobiosystems.com/","is_stealth":false,"normalized_domain":"interobiosystems.com","normalized_url_key":"interobiosystems.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://www.interobiosystems.com/wp-content/uploads/2024/06/cropped-ibio_logos_icon_blue.png","links":[{"label":"TechCrunch Battlefield Top 20","url":"https://techcrunch.com/2026/10/13/the-2026-startup-battlefield-top-20-from-organs-to-orbit-and-everything-in-between/"}],"entry_points":[{"kind":"homepage","url":"https://www.interobiosystems.com/","audience":"any","primary":true,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.interobiosystems.com/","audience":"any","primary":true,"listed_by":"community","on_listing_domain":true},"agent":{"kind":"homepage","url":"https://www.interobiosystems.com/","audience":"any","primary":true,"listed_by":"community","on_listing_domain":true}},"founders":[],"media":{"logo_asset_id":"2b440532-9ed3-4e93-a42f-81fe5bbd19d5"},"categories":["Biotech","Drug Discovery","Life Sciences","Organoids"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-10-14T04:27:25.259Z","added_via":"web","geo":null,"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-10-14T04:27:25.259Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"drug-discovery","name":"Drug discovery","note":null,"profile_url":"/industries/drug-discovery"},{"kind":"industry","slug":"life-sciences","name":"Life Sciences","note":null,"profile_url":"/industries/life-sciences"},{"kind":"industry","slug":"organoids","name":"Organoids","note":null,"profile_url":"/industries/organoids"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-10-14T04:27:25.259Z","updated_at":"2026-10-14T04:27:25.259Z"}},{"listing_type":"company","name":"Soufflé Therapeutics","slug":"souffle-therapeutics","tagline":"Cell-specific RNA therapies via receptor-mediated delivery","description":"Soufflé Therapeutics is a Boston biotechnology company building RNA therapies designed for cell-specific delivery outside the liver. Its REMEDY (Receptor Mediated Delivery) engine identifies internalizing receptors and generates proprietary binders to deliver oligonucleotide therapies to target cells and tissues. Programs include striated muscle for FSHD and cardiomyocytes for heart failure (HFrEF), among other muscle and metabolic disorders. On 13 October 2026 it raised $135 million in Series B financing led by Juvia Group, with participation from TCG Crossover, BB Biotech, Fidelity, Amgen Ventures, ARCH Venture Partners, Bessemer, Temasek, Leaps by Bayer, and others. CEO Amir Nashat leads the company.","url":"https://www.souffletx.com/","is_stealth":false,"normalized_domain":"souffletx.com","normalized_url_key":"souffletx.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://www.souffletx.com/file.cfm/1/docs/og_image.jpg","links":[{"label":"LinkedIn","url":"https://www.linkedin.com/company/souffletherapeutics","platform":"linkedin"},{"label":"FinSMEs: $135M Series B","url":"https://www.finsmes.com/2026/10/souffle-therapeutics-raises-135m-in-series-b-funding.html"}],"entry_points":[{"kind":"homepage","url":"https://www.souffletx.com/","audience":"any","primary":true,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.souffletx.com/","audience":"any","primary":true,"listed_by":"community","on_listing_domain":true},"agent":{"kind":"homepage","url":"https://www.souffletx.com/","audience":"any","primary":true,"listed_by":"community","on_listing_domain":true}},"founders":[{"name":"Amir Nashat","role":"CEO","person_slug":"amir-nashat-2f8t2wovw8ulx","bio":null,"location":null,"links":[]}],"media":{"logo_asset_id":"09a1661e-9c12-4c6f-8f6a-96fd044c2577"},"categories":["Biotech","Healthcare","Life Sciences"],"stage":"series-b+","founded_year":null,"location":"Boston, MA, USA","pricing":null,"twitter":null,"github":null,"linkedin":"https://www.linkedin.com/company/souffletherapeutics","contact_email":null,"added_at":"2026-10-13T16:42:34.595Z","added_via":"web","geo":null,"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-10-13T16:42:34.595Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"life-sciences","name":"Life Sciences","note":null,"profile_url":"/industries/life-sciences"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-10-13T16:42:34.595Z","updated_at":"2026-10-13T16:42:34.595Z"}},{"listing_type":"company","name":"Drylab","slug":"drylab","tagline":"AI bioinformatics platform that automates biomedical research workflows end to end","description":"Drylab (also known as Drylab AI) is an AI bioinformatics company founded in 2025 between Singapore and the US. Its platform helps life-science teams discover datasets, train custom models, and run one-click bioinformatics pipelines, and it builds research agents that can select from hundreds of scientific tools and databases with less constant human prompting. Co-founders include CEO John Phan, CTO/CRO Huy (Henry) Phan, and CSO Nhi Nguyen. In October 2026 it announced a US$3 million seed round led by Vertex Ventures with participation from PatSnap.","url":"https://thedrylab.com/","is_stealth":false,"normalized_domain":"thedrylab.com","normalized_url_key":"thedrylab.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://framerusercontent.com/images/uK7xiSRuBTr1Y7qeGfAIJ7tDtZk.png","links":[{"label":"Business Times seed coverage","url":"https://www.businesstimes.com.sg/startups-tech/startups/ai-agent-platform-drylab-ai-raises-us3-million-seed-round-vertex-ventures-and-patsnap"},{"label":"LinkedIn","url":"https://www.linkedin.com/company/drylab-ai","platform":"linkedin"}],"entry_points":[{"kind":"homepage","url":"https://thedrylab.com/","audience":"any","primary":true,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://thedrylab.com/","audience":"any","primary":true,"listed_by":"community","on_listing_domain":true},"agent":{"kind":"homepage","url":"https://thedrylab.com/","audience":"any","primary":true,"listed_by":"community","on_listing_domain":true}},"founders":[{"name":"John Phan","role":"Co-Founder and CEO","person_slug":"john-phan-0jnfaytob88ch","bio":null,"location":null,"links":[]},{"name":"Huy Phan","role":"Co-Founder, CTO and CRO","person_slug":"huy-phan-36gjjqrvlt9ze","bio":null,"location":null,"links":[]},{"name":"Nhi Nguyen","role":"Co-Founder and CSO","person_slug":"nhi-nguyen-38bjzmnz1dhve","bio":null,"location":null,"links":[]}],"media":{"logo_asset_id":"5080c02c-82a7-435a-a75c-306130879df1"},"categories":["AI","Bioinformatics","Biotech","Life Sciences","SaaS"],"stage":"seed","founded_year":null,"location":"Singapore / San Francisco, USA","pricing":null,"twitter":null,"github":null,"linkedin":"https://www.linkedin.com/company/drylab-ai","contact_email":null,"added_at":"2026-10-13T01:24:14.675Z","added_via":"web","geo":null,"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-10-13T01:24:14.675Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"ai","name":"AI","note":null,"profile_url":"/industries/ai"},{"kind":"industry","slug":"bioinformatics","name":"Bioinformatics","note":null,"profile_url":"/industries/bioinformatics"},{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"life-sciences","name":"Life Sciences","note":null,"profile_url":"/industries/life-sciences"},{"kind":"industry","slug":"saas","name":"SaaS","note":null,"profile_url":"/industries/saas"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-10-13T01:24:14.675Z","updated_at":"2026-10-13T01:24:14.675Z"}},{"listing_type":"company","name":"Breye Therapeutics","slug":"breye-therapeutics","tagline":"Oral ophthalmology drugs for early retinal disease","description":"Breye Therapeutics is a Copenhagen-area clinical-stage biopharmaceutical company developing orally administered therapies for early treatment of retinal diseases. Its lead asset is danegaptide, a small-molecule candidate intended to help protect retinal vasculature in diabetic retinopathy and related conditions, with a Phase 2 clinical proof-of-concept study planned to start in 2027. The company has also disclosed work on orally administered P2X7 receptor antagonists with anti-inflammatory and neuroprotective properties.","url":"https://breye.com/","is_stealth":false,"normalized_domain":"breye.com","normalized_url_key":"breye.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://breye.com/wp-content/uploads/2025/06/breye-favicon_s.png","links":[{"label":"LinkedIn","url":"https://www.linkedin.com/company/breye-therapeutics-aps","platform":"linkedin"}],"entry_points":[{"kind":"homepage","url":"https://breye.com/","audience":"human","primary":true,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://breye.com/","audience":"human","primary":true,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":{"logo_asset_id":"a35fbfbc-5559-4ee8-b57d-ab683cc4655c"},"categories":["Biotech","Healthcare","Life Sciences"],"stage":"series-a","founded_year":2019,"location":"Hørsholm, Denmark","pricing":null,"twitter":null,"github":null,"linkedin":"https://www.linkedin.com/company/breye-therapeutics-aps","contact_email":null,"added_at":"2026-10-02T20:24:46.279Z","added_via":"web","geo":null,"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-10-02T20:24:46.279Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"life-sciences","name":"Life Sciences","note":null,"profile_url":"/industries/life-sciences"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-10-02T20:24:46.279Z","updated_at":"2026-10-02T20:24:46.279Z"}},{"listing_type":"company","name":"Omnio","slug":"omnio","tagline":"Recombinant plasminogen therapy for hard-to-heal chronic wounds","description":"Omnio is a Umeå, Sweden biotech developing a recombinant plasminogen-based drug candidate to restart healing in chronic wounds such as diabetic foot ulcers. The company is advancing manufacturing toward GMP readiness and clinical development for wounds that fail conventional care. Based at Uminova Science Park.","url":"https://omnio.se/","is_stealth":false,"normalized_domain":"omnio.se","normalized_url_key":"omnio.se","parent_slug":null,"parent":null,"type_data":{},"logo":"https://omnio.se/wp-content/uploads/2025/04/OMNIO_LOGO_HORIZONTAL_BLACK_RGB-scaled.png","links":[],"entry_points":[{"kind":"homepage","url":"https://omnio.se/","audience":"any","primary":true,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://omnio.se/","audience":"any","primary":true,"listed_by":"community","on_listing_domain":true},"agent":{"kind":"homepage","url":"https://omnio.se/","audience":"any","primary":true,"listed_by":"community","on_listing_domain":true}},"founders":[],"media":{"logo_asset_id":"a48a826a-d7bf-487d-ab76-2fa1d6a0e0f9"},"categories":["Biotech","Health","Deep Tech","Life Sciences"],"stage":"seed","founded_year":null,"location":"Umeå, Sweden","pricing":null,"twitter":null,"github":null,"linkedin":"https://www.linkedin.com/company/omnio-ab","contact_email":"info@omnio.se","added_at":"2026-10-02T14:29:43.526Z","added_via":"web","geo":null,"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-10-02T14:29:43.526Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"deep-tech","name":"Deep Tech","note":null,"profile_url":"/industries/deep-tech"},{"kind":"industry","slug":"health","name":"Health","note":null,"profile_url":"/industries/health"},{"kind":"industry","slug":"life-sciences","name":"Life Sciences","note":null,"profile_url":"/industries/life-sciences"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-10-02T14:29:43.526Z","updated_at":"2026-10-02T14:29:43.526Z"}},{"listing_type":"company","name":"ai3Bio","slug":"ai3bio","tagline":"Therapeutics that target disease-causing T cells in autoimmunity","description":"ai3Bio develops therapies aimed at resetting the immune system by targeting pathogenic T cells rather than broadly suppressing immunity. Its approach includes an LNP/mRNA platform and an antibody platform designed to clear disease-causing T cells. The company announced a $48 million Series A at launch in September 2026.","url":"https://ai3.bio/","is_stealth":false,"normalized_domain":"ai3.bio","normalized_url_key":"ai3.bio","parent_slug":null,"parent":null,"type_data":{},"logo":"https://ai3.bio/wp-content/uploads/2026/09/favicon-300x300.png","links":[{"label":"LinkedIn","url":"https://www.linkedin.com/company/ai3-bio/","platform":"linkedin"}],"entry_points":[{"kind":"homepage","url":"https://ai3.bio/","audience":"any","primary":true,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://ai3.bio/","audience":"any","primary":true,"listed_by":"community","on_listing_domain":true},"agent":{"kind":"homepage","url":"https://ai3.bio/","audience":"any","primary":true,"listed_by":"community","on_listing_domain":true}},"founders":[],"media":{"logo_asset_id":"f2df2d6d-8324-4cd3-bed1-981f798f4636"},"categories":["Biotechnology","HealthTech","Therapeutics","AI","Life Sciences"],"stage":"series-a","founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":"https://www.linkedin.com/company/ai3-bio/","contact_email":null,"added_at":"2026-09-29T20:28:55.730Z","added_via":"web","geo":null,"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-29T20:28:55.730Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"ai","name":"AI","note":null,"profile_url":"/industries/ai"},{"kind":"industry","slug":"biotechnology","name":"Biotechnology","note":null,"profile_url":"/industries/biotechnology"},{"kind":"industry","slug":"healthtech","name":"HealthTech","note":null,"profile_url":"/industries/healthtech"},{"kind":"industry","slug":"life-sciences","name":"Life Sciences","note":null,"profile_url":"/industries/life-sciences"},{"kind":"industry","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/industries/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-29T20:28:55.730Z","updated_at":"2026-09-29T20:28:55.730Z"}},{"listing_type":"company","name":"Prezent","slug":"prezent","tagline":"AI-native life sciences communications partner combining agents and experts.","description":"Prezent builds AI-native communication tools for life sciences and biopharma teams. Its Prezent Vivo offering combines self-serve AI (including the Astrid agent), overnight presentation services, and fixed-price expert projects to produce brand-compliant scientific and commercial decks, posters, and related materials. The company serves biopharma and specialized agencies via prezent.ai.","url":"https://www.prezent.ai/","is_stealth":false,"normalized_domain":"prezent.ai","normalized_url_key":"prezent.ai","parent_slug":null,"parent":null,"type_data":{},"logo":null,"links":[{"label":"X / Twitter","url":"https://x.com/theprezentai","platform":"x"},{"label":"LinkedIn","url":"https://www.linkedin.com/company/prezent-ai","platform":"linkedin"}],"entry_points":[{"kind":"homepage","url":"https://www.prezent.ai/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.prezent.ai/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":{"logo_asset_id":"28edc198-61c5-4f38-8c7f-d1f9e7e53fd9"},"categories":["AI","Life Sciences","Enterprise Software","Communications"],"stage":"growth","founded_year":null,"location":null,"pricing":null,"twitter":"https://x.com/theprezentai","github":null,"linkedin":"https://www.linkedin.com/company/prezent-ai","contact_email":null,"added_at":"2026-09-26T14:22:46.376Z","added_via":"web","geo":null,"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-26T14:25:08.516Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"ai","name":"AI","note":null,"profile_url":"/industries/ai"},{"kind":"industry","slug":"communications","name":"Communications","note":null,"profile_url":"/industries/communications"},{"kind":"industry","slug":"enterprise-software","name":"Enterprise Software","note":null,"profile_url":"/industries/enterprise-software"},{"kind":"industry","slug":"life-sciences","name":"Life Sciences","note":null,"profile_url":"/industries/life-sciences"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-26T14:22:46.376Z","updated_at":"2026-09-26T14:22:46.376Z"}},{"listing_type":"company","name":"Ordo Labs","slug":"ordo-labs","tagline":"AI workspace for regulated science labs","description":"Ordo Labs (Stockholm) builds Ordo, an AI workspace for laboratories working under GMP, GLP, 21 CFR Part 11, and EU GMP Annex 11. The product runs SOP-defined QC checks, drafts audit-ready reports from instrument and LIMS exports, and keeps every value linked to its source file. Founded by Kristina Hoang, Sebastian Apelgren, and Adam Tovatt; Y Combinator Fall 2026.","url":"https://ordolabs.ai/","is_stealth":false,"normalized_domain":"ordolabs.ai","normalized_url_key":"ordolabs.ai","parent_slug":null,"parent":null,"type_data":{},"logo":"https://ordolabs.ai/icons/OrdoIcon180.png","links":[],"entry_points":[{"kind":"homepage","url":"https://ordolabs.ai/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://ordolabs.ai/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[{"name":"Kristina Hoang","role":"Co-founder","person_slug":"kristina-hoang-2lcngrmpdknc4","bio":null,"location":null,"links":[]},{"name":"Sebastian Apelgren","role":"Co-founder","person_slug":"sebastian-apelgren-01do5kipnub30","bio":null,"location":null,"links":[]},{"name":"Adam Tovatt","role":"Co-founder","person_slug":"adam-tovatt-3q5ah3swf1d71","bio":null,"location":null,"links":[]}],"media":{"logo_asset_id":"e1c0ac6c-acf7-4d23-8dda-0f73140d1c3d"},"categories":["AI","Healthcare","Life Sciences","SaaS","B2B"],"stage":"seed","founded_year":null,"location":"Stockholm, Sweden","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-25T17:18:26.742Z","added_via":"web","geo":null,"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-25T17:18:26.742Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"ai","name":"AI","note":null,"profile_url":"/industries/ai"},{"kind":"industry","slug":"b2b","name":"B2B","note":null,"profile_url":"/industries/b2b"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"life-sciences","name":"Life Sciences","note":null,"profile_url":"/industries/life-sciences"},{"kind":"industry","slug":"saas","name":"SaaS","note":null,"profile_url":"/industries/saas"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-25T17:18:26.742Z","updated_at":"2026-09-25T17:18:26.742Z"}},{"listing_type":"company","name":"Biolevate","slug":"biolevate","tagline":"Evidence-grade AI platform for regulated life sciences operations","description":"Biolevate is a Paris-based life sciences AI company building an enterprise agentic platform that turns scientific and regulatory knowledge into auditable, source-linked workflows. Its governed workflows span research, clinical, regulatory, market access, and manufacturing use cases while keeping human oversight and an evidence trail for regulated teams.","url":"https://www.biolevate.com/","is_stealth":false,"normalized_domain":"biolevate.com","normalized_url_key":"biolevate.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://framerusercontent.com/images/u46w6cuObImDwKkKdTjFeJHxO4.png","links":[{"label":"X / Twitter","url":"https://x.com/Biolevate","platform":"x"},{"label":"LinkedIn","url":"https://www.linkedin.com/company/biolevate","platform":"linkedin"},{"label":"YouTube","url":"https://www.youtube.com/@Biolevate","platform":"youtube"}],"entry_points":[{"kind":"homepage","url":"https://www.biolevate.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.biolevate.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[{"name":"Joël Belafa","role":"Co-founder and CEO","person_slug":"jo-l-belafa-3043db54xqlgj","bio":null,"location":null,"links":[]}],"media":{"logo_asset_id":"1f49bdb3-1f84-4840-aa83-a41d932098ac"},"categories":["AI","Healthtech","Life Sciences"],"stage":"series-a","founded_year":2023,"location":"Paris, France","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-22T11:16:10.625Z","added_via":"web","geo":null,"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-22T11:16:10.625Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"ai","name":"AI","note":null,"profile_url":"/industries/ai"},{"kind":"industry","slug":"healthtech","name":"HealthTech","note":null,"profile_url":"/industries/healthtech"},{"kind":"industry","slug":"life-sciences","name":"Life Sciences","note":null,"profile_url":"/industries/life-sciences"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-22T11:16:10.625Z","updated_at":"2026-09-22T11:16:10.625Z"}},{"listing_type":"company","name":"Reveal HealthTech","slug":"reveal-healthtech","tagline":"AI transformation partner for US healthcare and life sciences","description":"Reveal HealthTech builds AI solutions for healthcare and life-sciences organizations, combining clinical domain expertise with engineering. Flagship offerings include BioCanvas for multimodal clinical and trial data use cases and Prism AI for intelligent workflow agents. The company is based across New York and Bangalore and was incubated by W Health Ventures and 2070 Health.","url":"https://revealhealthtech.com/","is_stealth":false,"normalized_domain":"revealhealthtech.com","normalized_url_key":"revealhealthtech.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://mma.prnewswire.com/media/2763629/Reveal_HealthTech_Logo.jpg","links":[{"label":"LinkedIn","url":"https://www.linkedin.com/company/reveal-healthtech","platform":"linkedin"},{"label":"BioCanvas","url":"https://revealhealthtech.com/biocanvas"},{"label":"AI Lab","url":"https://revealhealthtech.com/ai-lab"}],"entry_points":[{"kind":"homepage","url":"https://revealhealthtech.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://revealhealthtech.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[{"name":"Sanchit Mullick","role":"Founder and CEO","person_slug":"sanchit-mullick-3m1ukn40yum8u","bio":null,"location":null,"links":[]},{"name":"Dr Salim Afshar","role":"Founder and CMIO","person_slug":"dr-salim-afshar-0myb2tmcz5lvy","bio":null,"location":null,"links":[]}],"media":{"logo_asset_id":"fb867606-7e9c-4a8b-a6bf-45120c7834d9"},"categories":["Health Tech","AI","Life Sciences","Enterprise Software","B2B"],"stage":"series-a","founded_year":null,"location":"New York, USA / Bangalore, India","pricing":null,"twitter":null,"github":null,"linkedin":"https://www.linkedin.com/company/reveal-healthtech","contact_email":null,"added_at":"2026-09-19T08:15:03.587Z","added_via":"web","geo":null,"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-19T08:15:03.587Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"ai","name":"AI","note":null,"profile_url":"/industries/ai"},{"kind":"industry","slug":"b2b","name":"B2B","note":null,"profile_url":"/industries/b2b"},{"kind":"industry","slug":"enterprise-software","name":"Enterprise Software","note":null,"profile_url":"/industries/enterprise-software"},{"kind":"industry","slug":"health-tech","name":"Health Tech","note":null,"profile_url":"/industries/health-tech"},{"kind":"industry","slug":"life-sciences","name":"Life Sciences","note":null,"profile_url":"/industries/life-sciences"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-19T08:15:03.587Z","updated_at":"2026-09-19T08:15:03.587Z"}},{"listing_type":"company","name":"Graph AI","slug":"graph-ai","tagline":"AI-native pharmacovigilance and patient safety platform company","description":"Graph AI develops Graph Safety, an AI-native operating system for pharmacovigilance and patient safety workflows. The company focuses on unifying adverse-event intake, case processing, reporting, and related safety operations for pharmaceutical and biotechnology teams, with emphasis on traceability and human oversight. Public site: graphsafety.ai.","url":"https://graphsafety.ai/","is_stealth":false,"normalized_domain":"graphsafety.ai","normalized_url_key":"graphsafety.ai","parent_slug":null,"parent":null,"type_data":{},"logo":"https://graphsafety.ai/wp-content/uploads/2026/06/favicon.png","links":[{"label":"LinkedIn","url":"https://www.linkedin.com/company/graphsafety/","platform":"linkedin"},{"label":"YouTube","url":"https://www.youtube.com/@graphsafety","platform":"youtube"}],"entry_points":[{"kind":"homepage","url":"https://graphsafety.ai/","audience":"any","primary":true,"listed_by":"community","on_listing_domain":true},{"kind":"contact","url":"https://graphsafety.ai/contact/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://graphsafety.ai/","audience":"any","primary":true,"listed_by":"community","on_listing_domain":true},"agent":{"kind":"homepage","url":"https://graphsafety.ai/","audience":"any","primary":true,"listed_by":"community","on_listing_domain":true}},"founders":[{"name":"Raghav Parvataraju","role":"CEO","person_slug":"raghav-parvataraju-09dlucdlsq2gc","bio":null,"location":null,"links":[]}],"media":{"logo_asset_id":"5e5311c7-4c6d-4c98-8009-e283f69bdbc1"},"categories":["Healthtech","AI","Enterprise Software","Life Sciences","SaaS"],"stage":"series-a","founded_year":2024,"location":"Pleasanton, CA","pricing":null,"twitter":null,"github":null,"linkedin":"https://www.linkedin.com/company/graphsafety/","contact_email":null,"added_at":"2026-09-10T20:21:04.483Z","added_via":"web","geo":null,"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-10T20:21:04.483Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"ai","name":"AI","note":null,"profile_url":"/industries/ai"},{"kind":"industry","slug":"enterprise-software","name":"Enterprise Software","note":null,"profile_url":"/industries/enterprise-software"},{"kind":"industry","slug":"healthtech","name":"HealthTech","note":null,"profile_url":"/industries/healthtech"},{"kind":"industry","slug":"life-sciences","name":"Life Sciences","note":null,"profile_url":"/industries/life-sciences"},{"kind":"industry","slug":"saas","name":"SaaS","note":null,"profile_url":"/industries/saas"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-10T20:21:04.483Z","updated_at":"2026-09-10T20:21:04.483Z"}},{"listing_type":"company","name":"BrainChild Bio","slug":"brainchild-bio","tagline":"Kids-first clinical-stage biotech developing CAR T therapies for CNS tumors","description":"BrainChild Bio is a clinical-stage biotechnology company developing CAR T cell therapies for tumors in the central nervous system. It prioritizes pediatric brain tumors, including diffuse intrinsic pontine glioma (DIPG), with plans to expand its platform to adult CNS indications such as glioblastoma. The company is based in Seattle and Cambridge and spun out of research at Seattle Children’s.","url":"https://brainchildbio.com/","is_stealth":false,"normalized_domain":"brainchildbio.com","normalized_url_key":"brainchildbio.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://brainchildbio.com/wp-content/uploads/2025/04/cropped-apple-touch-icon@1024x-180x180.png","links":[{"label":"LinkedIn","url":"https://www.linkedin.com/company/brainchildbio","platform":"linkedin"}],"entry_points":[{"kind":"homepage","url":"https://brainchildbio.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://brainchildbio.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[{"name":"Steven Brugger","role":"Chief Executive Officer","person_slug":"steven-brugger-1f582la7uxnwh","bio":null,"location":null,"links":[]}],"media":{"logo_asset_id":"586c7788-035c-419d-b349-87d2bf0bde60"},"categories":["Healthcare","Biotech","Life Sciences"],"stage":"series-a","founded_year":2023,"location":"Seattle, United States","pricing":null,"twitter":null,"github":null,"linkedin":"https://www.linkedin.com/company/brainchildbio","contact_email":null,"added_at":"2026-09-10T02:26:09.089Z","added_via":"web","geo":null,"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-10T02:26:09.089Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"life-sciences","name":"Life Sciences","note":null,"profile_url":"/industries/life-sciences"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-10T02:26:09.089Z","updated_at":"2026-09-10T02:26:09.089Z"}},{"listing_type":"accelerator","name":"Springboard Enterprises","slug":"springboard-enterprises","tagline":"A Washington DC-based accelerator and ecosystem that has helped women-led companies raise over $35 billion in funding since 2000.","description":"Springboard Enterprises is a Washington, DC-based non-profit accelerator founded in 2000 that focuses exclusively on women-led and women-founded companies in technology, media, life sciences, and sustainability. Through its flagship Venture Sprint bootcamps and year-round programming, Springboard connects founders with investors, mentors, and a community of 800+ alumni companies. Alumni of Springboard have collectively raised over $35 billion in funding. The organization runs multiple regional programs across the United States.","url":"https://sb.co/","is_stealth":false,"normalized_domain":"sb.co","normalized_url_key":"sb.co","parent_slug":null,"parent":null,"type_data":{"application_url":"https://sb.co/apply/","application_status":"rolling","formats":["In person","Hybrid"],"focus_areas":["Women-Led","Tech","Life Sciences","Media","Sustainability"],"cohort_frequency":"Multiple bootcamps per year","portfolio_url":"https://sb.co/portfolio/"},"logo":null,"links":[{"label":"Apply","url":"https://sb.co/apply/","platform":"apply"}],"entry_points":[{"kind":"homepage","url":"https://sb.co/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},{"kind":"apply","url":"https://sb.co/apply/","audience":"human","primary":false,"listed_by":"community","derived_from":"type_data.application_url","on_listing_domain":true},{"kind":"portfolio","url":"https://sb.co/portfolio/","audience":"any","primary":false,"listed_by":"community","derived_from":"type_data.portfolio_url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://sb.co/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Accelerator","Women Founders","Non-Profit","Life Sciences","Tech","Women-Led","Media","Sustainability"],"stage":null,"founded_year":2000,"location":"Washington, DC, USA","pricing":null,"twitter":"https://x.com/SBEntrepreneur","github":null,"linkedin":"https://www.linkedin.com/company/springboard-enterprises/","contact_email":null,"added_at":"2026-09-04T03:56:08.247Z","added_via":"web","geo":{"keywords":["Accelerator","Startup accelerator","Women-Led","Tech","Life Sciences","Media","Sustainability"],"canonical_facts":["Cohorts: Multiple bootcamps per year"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-04T03:56:08.247Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"accelerator","name":"Accelerator","note":null,"profile_url":"/industries/accelerator"},{"kind":"industry","slug":"life-sciences","name":"Life Sciences","note":null,"profile_url":"/industries/life-sciences"},{"kind":"industry","slug":"media","name":"Media","note":null,"profile_url":"/industries/media"},{"kind":"industry","slug":"non-profit","name":"Non-Profit","note":null,"profile_url":"/industries/non-profit"},{"kind":"industry","slug":"sustainability","name":"Sustainability","note":null,"profile_url":"/industries/sustainability"},{"kind":"industry","slug":"tech","name":"Tech","note":null,"profile_url":"/industries/tech"},{"kind":"industry","slug":"women-founders","name":"Women Founders","note":null,"profile_url":"/industries/women-founders"},{"kind":"industry","slug":"women-led","name":"Women-Led","note":null,"profile_url":"/industries/women-led"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-04T03:56:08.247Z","updated_at":"2026-09-04T03:56:08.247Z"}},{"listing_type":"accelerator","name":"Villgro Africa","slug":"villgro-africa","tagline":"Nairobi-based healthcare-focused incubator and impact investor supporting emerging health businesses across Africa.","description":"Villgro Africa is a Nairobi-based incubator and impact investor that supports early-stage health and life sciences startups across Africa through personalised incubation, seed funding, and industry advisory. It has deployed $3.3M+ in seed funding with $49M+ in follow-on funding attracted and 20M+ lives impacted. Programmes include a women-focused incubation initiative and an Expert-Led Immersion Program for MedTech and BioTech startups bridging the gap from invention to enterprise.","url":"https://villgroafrica.org/","is_stealth":false,"normalized_domain":"villgroafrica.org","normalized_url_key":"villgroafrica.org","parent_slug":null,"parent":null,"type_data":{"application_url":"https://villgroafrica.org/","application_status":"rolling","formats":["In person"],"focus_areas":["Healthcare","MedTech","BioTech","Life Sciences","Digital Health"],"funding_offer":"Seed funding and access to impact investors"},"logo":null,"links":[{"label":"Apply","url":"https://villgroafrica.org/","platform":"apply"}],"entry_points":[{"kind":"homepage","url":"https://villgroafrica.org/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://villgroafrica.org/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Accelerator","Healthcare","MedTech","BioTech","Kenya","Pan-African","Impact","Life Sciences"],"stage":null,"founded_year":null,"location":"Nairobi, Kenya","pricing":null,"twitter":null,"github":null,"linkedin":"https://www.linkedin.com/company/villgro-africa/","contact_email":null,"added_at":"2026-09-04T03:54:32.384Z","added_via":"web","geo":{"keywords":["Accelerator","Startup accelerator","Healthcare","MedTech","BioTech","Life Sciences","Digital Health"],"canonical_facts":["Funding offer: Seed funding and access to impact investors"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-04T03:54:32.384Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"accelerator","name":"Accelerator","note":null,"profile_url":"/industries/accelerator"},{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"impact","name":"Impact","note":null,"profile_url":"/industries/impact"},{"kind":"industry","slug":"kenya","name":"Kenya","note":null,"profile_url":"/industries/kenya"},{"kind":"industry","slug":"life-sciences","name":"Life Sciences","note":null,"profile_url":"/industries/life-sciences"},{"kind":"industry","slug":"medtech","name":"MedTech","note":null,"profile_url":"/industries/medtech"},{"kind":"industry","slug":"pan-african","name":"Pan-African","note":null,"profile_url":"/industries/pan-african"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-04T03:54:32.384Z","updated_at":"2026-09-04T03:54:32.384Z"}},{"listing_type":"accelerator","name":"Deep Science Ventures","slug":"deep-science-ventures","tagline":"London venture creator combining scientific knowledge and founder-type scientists to build high-impact deep-tech companies.","description":"Deep Science Ventures (DSV) is a London-based venture creator that systematically builds startups by combining available scientific knowledge with founder-type scientists. It focuses on five sectors: restorative cultivation (agriculture), scaling intelligence (computation), reversing global heating (climate), curative therapeutics (pharma), and education via the Venture Science Doctorate. DSV has launched 58+ companies with 12 in active development, and attracts GBP 220M+ in portfolio valuation.","url":"https://www.deepscienceventures.com/","is_stealth":false,"normalized_domain":"deepscienceventures.com","normalized_url_key":"deepscienceventures.com","parent_slug":null,"parent":null,"type_data":{"application_status":"rolling","formats":["In person"],"focus_areas":["Deep Tech","Agriculture","Climate","Pharma","AI/Computation","Life Sciences"]},"logo":null,"links":[],"entry_points":[{"kind":"homepage","url":"https://www.deepscienceventures.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.deepscienceventures.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Accelerator","Venture Builder","Deep Tech","Climate","Pharma","Agriculture","Life Sciences","AI/Computation"],"stage":null,"founded_year":null,"location":"London, United Kingdom","pricing":null,"twitter":null,"github":null,"linkedin":"https://www.linkedin.com/company/deep-science-ventures/","contact_email":null,"added_at":"2026-09-04T03:54:10.155Z","added_via":"web","geo":{"keywords":["Accelerator","Startup accelerator","Deep Tech","Agriculture","Climate","Pharma","AI/Computation","Life Sciences"],"canonical_facts":[]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-04T03:54:10.155Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"accelerator","name":"Accelerator","note":null,"profile_url":"/industries/accelerator"},{"kind":"industry","slug":"agriculture","name":"Agriculture","note":null,"profile_url":"/industries/agriculture"},{"kind":"industry","slug":"ai-computation","name":"AI/Computation","note":null,"profile_url":"/industries/ai-computation"},{"kind":"industry","slug":"climate","name":"Climate","note":null,"profile_url":"/industries/climate"},{"kind":"industry","slug":"deep-tech","name":"Deep Tech","note":null,"profile_url":"/industries/deep-tech"},{"kind":"industry","slug":"life-sciences","name":"Life Sciences","note":null,"profile_url":"/industries/life-sciences"},{"kind":"industry","slug":"pharma","name":"Pharma","note":null,"profile_url":"/industries/pharma"},{"kind":"industry","slug":"venture-builder","name":"Venture Builder","note":null,"profile_url":"/industries/venture-builder"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-04T03:54:10.155Z","updated_at":"2026-09-04T03:54:10.155Z"}},{"listing_type":"accelerator","name":"Conception X","slug":"conception-x","tagline":"Deep-tech accelerator turning PhD researchers into venture founders through a nine-month fellowship programme.","description":"Conception X is a UK-based deep-tech accelerator founded in 2018 that works with PhD researchers across Europe's leading research institutions to test whether their research can become scalable startups. Its flagship Venture Scientist 100 (VS100) is a nine-month fellowship supporting approximately 100 PhD founders per year through 18 co-building sessions, with investment and expert coaching for top teams. Since 2018 it has launched 700+ founders and created 205 startups with a portfolio valued at over GBP 1B. VS100 applications open in September 2026.\n\nProgram duration: 9 months.","url":"https://www.conceptionx.org/","is_stealth":false,"normalized_domain":"conceptionx.org","normalized_url_key":"conceptionx.org","parent_slug":null,"parent":null,"type_data":{"application_url":"https://conceptionx.org/","application_status":"open","formats":["Hybrid"],"focus_areas":["Deep Tech","Life Sciences","AI","Energy","Advanced Materials","Robotics"],"funding_offer":"Investment and expert coaching for top teams (amount not specified publicly)","cohort_frequency":"Annual"},"logo":null,"links":[{"label":"Apply","url":"https://conceptionx.org/","platform":"apply"}],"entry_points":[{"kind":"homepage","url":"https://www.conceptionx.org/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.conceptionx.org/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Accelerator","Deep Tech","PhD Founders","Life Sciences","AI","Research Commercialisation","Energy","Advanced Materials"],"stage":null,"founded_year":2018,"location":"London, United Kingdom","pricing":null,"twitter":null,"github":null,"linkedin":"https://www.linkedin.com/company/conception-x/","contact_email":null,"added_at":"2026-09-04T03:54:07.234Z","added_via":"web","geo":{"keywords":["Accelerator","Startup accelerator","Deep Tech","Life Sciences","AI","Energy","Advanced Materials","Robotics"],"canonical_facts":["Program duration: 9 months","Funding offer: Investment and expert coaching for top teams (amount not specified publicly)","Cohorts: Annual"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-04T03:54:07.234Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"accelerator","name":"Accelerator","note":null,"profile_url":"/industries/accelerator"},{"kind":"industry","slug":"advanced-materials","name":"Advanced Materials","note":null,"profile_url":"/industries/advanced-materials"},{"kind":"industry","slug":"ai","name":"AI","note":null,"profile_url":"/industries/ai"},{"kind":"industry","slug":"deep-tech","name":"Deep Tech","note":null,"profile_url":"/industries/deep-tech"},{"kind":"industry","slug":"energy","name":"Energy","note":null,"profile_url":"/industries/energy"},{"kind":"industry","slug":"life-sciences","name":"Life Sciences","note":null,"profile_url":"/industries/life-sciences"},{"kind":"industry","slug":"phd-founders","name":"PhD Founders","note":null,"profile_url":"/industries/phd-founders"},{"kind":"industry","slug":"research-commercialisation","name":"Research Commercialisation","note":null,"profile_url":"/industries/research-commercialisation"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-04T03:54:07.234Z","updated_at":"2026-09-04T03:54:07.234Z"}},{"listing_type":"accelerator","name":"Bayer Co.Lab","slug":"bayer-co-lab","tagline":"Bayer's global network of life science incubators providing early-stage biotech startups with lab space, expert mentorship, and access to Bayer's worldwide…","description":"Bayer Co.Lab is a global network of life science incubators with locations in Berlin, Cambridge (US), Kobe, and Shanghai, providing early-stage entrepreneurs with state-of-the-art facilities, expert mentorship, and connections to Bayer's global research networks with no strings attached. The Co.Lab Connect program offers region-specific programs in Basel and Seoul to bridge local startups to global markets, particularly the US ecosystem. In 2025, the program selected Rege Nephro (Japan) and NXI Therapeutics (Switzerland) as inaugural Co.Lab Connect recipients.","url":"https://colab.bayer.com/","is_stealth":false,"normalized_domain":"colab.bayer.com","normalized_url_key":"colab.bayer.com","parent_slug":null,"parent":null,"type_data":{"application_url":"https://colab.bayer.com/","application_status":"rolling","formats":["In person"],"focus_areas":["Biotech","Pharmaceuticals","Life Sciences","Digital Health"],"equity_terms":"no strings attached","cohort_frequency":"rolling","portfolio_url":"https://colab.bayer.com/"},"logo":null,"links":[{"label":"Apply","url":"https://colab.bayer.com/","platform":"apply"}],"entry_points":[{"kind":"homepage","url":"https://colab.bayer.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://colab.bayer.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Accelerator","Incubator","Corporate","Biotech","Life Sciences","Pharmaceuticals","Digital Health"],"stage":null,"founded_year":null,"location":"Multiple (Berlin, Germany; Cambridge, USA; Kobe, Japan; Shanghai, China)","pricing":null,"twitter":null,"github":null,"linkedin":"https://www.linkedin.com/company/bayer-co-lab/","contact_email":null,"added_at":"2026-09-04T03:51:05.029Z","added_via":"web","geo":{"keywords":["Accelerator","Startup accelerator","Biotech","Pharmaceuticals","Life Sciences","Digital Health"],"canonical_facts":["Run by Bayer","Equity terms: no strings attached","Cohorts: rolling"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-04T03:51:05.029Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"accelerator","name":"Accelerator","note":null,"profile_url":"/industries/accelerator"},{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"corporate","name":"Corporate","note":null,"profile_url":"/industries/corporate"},{"kind":"industry","slug":"digital-health","name":"Digital Health","note":null,"profile_url":"/industries/digital-health"},{"kind":"industry","slug":"incubator","name":"Incubator","note":null,"profile_url":"/industries/incubator"},{"kind":"industry","slug":"life-sciences","name":"Life Sciences","note":null,"profile_url":"/industries/life-sciences"},{"kind":"industry","slug":"pharmaceuticals","name":"Pharmaceuticals","note":null,"profile_url":"/industries/pharmaceuticals"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-04T03:51:05.029Z","updated_at":"2026-09-04T03:51:05.029Z"}},{"listing_type":"accelerator","name":"Nucleate Activator","slug":"nucleate-activator","tagline":"A free, equity-free six-month global accelerator for academic biotech founders that has supported 400+ life science ventures raising $420 million in venture…","description":"Nucleate Activator is a nonprofit-run, six-month equity-free program for academic scientists and early professionals launching biotech ventures, with chapters in 40+ regions and 200+ academic institutions worldwide. The program provides mutual-matching team formation, mentorship from biotech executives and investors, legal strategy, clinical consulting, and pitch showcases before expert judges. In 2025, the program selected 197 teams from 2,000+ applications across therapeutics, synthetic biology, diagnostics, and climate tech. Sponsors include Alnylam, Eli Lilly, Genentech, and MilliporeSigma.\n\nProgram duration: 6 months.","url":"https://nucleate.org/activator/","is_stealth":false,"normalized_domain":"nucleate.org","normalized_url_key":"nucleate.org","parent_slug":null,"parent":null,"type_data":{"application_url":"https://nucleate.org/activator/","application_status":"upcoming","formats":["Hybrid"],"focus_areas":["Biotech","Life Sciences","Therapeutics","Synthetic Biology","Diagnostics"],"equity_terms":"equity-free, no program fees","cohort_frequency":"annual","portfolio_url":"https://nucleate.org/portfolio/"},"logo":null,"links":[{"label":"Apply","url":"https://nucleate.org/activator/","platform":"apply"}],"entry_points":[{"kind":"homepage","url":"https://nucleate.org/activator/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},{"kind":"portfolio","url":"https://nucleate.org/portfolio/","audience":"any","primary":false,"listed_by":"community","derived_from":"type_data.portfolio_url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://nucleate.org/activator/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Accelerator","Biotech","Life Sciences","Academic","Non-profit","Therapeutics","Synthetic Biology","Diagnostics"],"stage":null,"founded_year":null,"location":"Multiple (Boston, Bay Area, New York, and 40+ global regions)","pricing":null,"twitter":null,"github":null,"linkedin":"https://www.linkedin.com/company/nucleateactivator/","contact_email":null,"added_at":"2026-09-04T03:51:02.979Z","added_via":"web","geo":{"keywords":["Accelerator","Startup accelerator","Biotech","Life Sciences","Therapeutics","Synthetic Biology","Diagnostics"],"canonical_facts":["Run by Nucleate","Program duration: 6 months","Equity terms: equity-free, no program fees","Cohorts: annual"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-04T03:51:02.979Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"academic","name":"Academic","note":null,"profile_url":"/industries/academic"},{"kind":"industry","slug":"accelerator","name":"Accelerator","note":null,"profile_url":"/industries/accelerator"},{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"diagnostics","name":"Diagnostics","note":null,"profile_url":"/industries/diagnostics"},{"kind":"industry","slug":"life-sciences","name":"Life Sciences","note":null,"profile_url":"/industries/life-sciences"},{"kind":"industry","slug":"non-profit","name":"Non-Profit","note":null,"profile_url":"/industries/non-profit"},{"kind":"industry","slug":"synthetic-biology","name":"Synthetic Biology","note":null,"profile_url":"/industries/synthetic-biology"},{"kind":"industry","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/industries/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-04T03:51:02.979Z","updated_at":"2026-09-04T03:51:02.979Z"}},{"listing_type":"accelerator","name":"MedTech Innovator","slug":"medtech-innovator","tagline":"The world's largest life science accelerator, selecting 50+ medtech, diagnostics, and digital health startups annually for a five-month virtual program with…","description":"MedTech Innovator is a remote-friendly accelerator and industry showcase for early- to mid-stage medical device, diagnostic, and digital health companies from Seed through Series C. Its five-month virtual accelerator runs June through November, featuring expert mentorship from corporate partners, investor access, and pitch competitions at The MedTech Conference. Early-stage companies (pre-Series B) compete for up to $350,000 in funding. The program also runs MTI Asia Pacific and BioTools Innovator programs. Since 2013, 717+ alumni companies have secured $10.3 billion in follow-on equity funding.\n\nProgram duration: 5 months (June–November).","url":"https://medtechinnovator.org/","is_stealth":false,"normalized_domain":"medtechinnovator.org","normalized_url_key":"medtechinnovator.org","parent_slug":null,"parent":null,"type_data":{"application_url":"https://medtechinnovator.org/apply/","application_status":"upcoming","formats":["Remote"],"focus_areas":["Medical Devices","Digital Health","Diagnostics","Life Science Tools"],"funding_offer":"Up to $350,000 (US program); up to $300,000 (Asia Pacific); up to $250,000 (BioTools Innovator)","cohort_frequency":"annual","portfolio_url":"https://medtechinnovator.org/portfolio/"},"logo":null,"links":[{"label":"Apply","url":"https://medtechinnovator.org/apply/","platform":"apply"}],"entry_points":[{"kind":"homepage","url":"https://medtechinnovator.org/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},{"kind":"apply","url":"https://medtechinnovator.org/apply/","audience":"human","primary":false,"listed_by":"community","derived_from":"type_data.application_url","on_listing_domain":true},{"kind":"portfolio","url":"https://medtechinnovator.org/portfolio/","audience":"any","primary":false,"listed_by":"community","derived_from":"type_data.portfolio_url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://medtechinnovator.org/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Accelerator","MedTech","Digital Health","Life Sciences","Healthcare","Medical Devices","Diagnostics","Life Science Tools"],"stage":null,"founded_year":2013,"location":"Los Angeles, USA","pricing":null,"twitter":"https://x.com/MedTechInn","github":null,"linkedin":"https://www.linkedin.com/company/medtech-innovator/","contact_email":null,"added_at":"2026-09-04T03:50:17.858Z","added_via":"web","geo":{"keywords":["Accelerator","Startup accelerator","Medical Devices","Digital Health","Diagnostics","Life Science Tools"],"canonical_facts":["Program duration: 5 months (June–November)","Funding offer: Up to $350,000 (US program); up to $300,000 (Asia Pacific); up to $250,000 (BioTools Innovator)","Cohorts: annual"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-04T03:50:17.858Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"accelerator","name":"Accelerator","note":null,"profile_url":"/industries/accelerator"},{"kind":"industry","slug":"diagnostics","name":"Diagnostics","note":null,"profile_url":"/industries/diagnostics"},{"kind":"industry","slug":"digital-health","name":"Digital Health","note":null,"profile_url":"/industries/digital-health"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"life-science-tools","name":"Life Science Tools","note":null,"profile_url":"/industries/life-science-tools"},{"kind":"industry","slug":"life-sciences","name":"Life Sciences","note":null,"profile_url":"/industries/life-sciences"},{"kind":"industry","slug":"medical-devices","name":"Medical Devices","note":null,"profile_url":"/industries/medical-devices"},{"kind":"industry","slug":"medtech","name":"MedTech","note":null,"profile_url":"/industries/medtech"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-04T03:50:17.858Z","updated_at":"2026-09-04T03:50:17.858Z"}},{"listing_type":"accelerator","name":"IndieBio (SOSV)","slug":"indiebio-sosv","tagline":"The world's leading early-stage biotech and life science accelerator providing pre-seed investment and on-site laboratory access to scientists launching…","description":"IndieBio is SOSV's life science and deep tech accelerator with locations in San Francisco and New York City, offering pre-seed investment and on-site bio-lab access to biotech, synthetic biology, and life science founders since 2015. The program runs multiple cohorts per year in each city, culminating in demo days that attract top life sciences investors. In early 2026, IndieBio rebranded to SOSV SF and SOSV NY to reflect a broader deep tech scope encompassing biology, chemistry, physics, and AI.","url":"https://indiebio.co/","is_stealth":false,"normalized_domain":"indiebio.co","normalized_url_key":"indiebio.co","parent_slug":null,"parent":null,"type_data":{"application_url":"https://sosv.com/apply/","application_status":"rolling","formats":["In person"],"focus_areas":["Biotech","Life Sciences","Synthetic Biology","Diagnostics","Deep Tech"],"funding_offer":"Pre-seed investment (amount varies per company)","cohort_frequency":"multiple cohorts per year","portfolio_url":"https://sosv.com/portfolio/"},"logo":null,"links":[{"label":"Apply","url":"https://sosv.com/apply/","platform":"apply"}],"entry_points":[{"kind":"homepage","url":"https://indiebio.co/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},{"kind":"apply","url":"https://sosv.com/apply/","audience":"human","primary":false,"listed_by":"community","derived_from":"type_data.application_url","on_listing_domain":false},{"kind":"portfolio","url":"https://sosv.com/portfolio/","audience":"any","primary":false,"listed_by":"community","derived_from":"type_data.portfolio_url","on_listing_domain":false}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://indiebio.co/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Accelerator","Biotech","Life Sciences","Deep Tech","Synthetic Biology","Diagnostics"],"stage":null,"founded_year":2015,"location":"San Francisco, USA","pricing":null,"twitter":"https://x.com/indiebio","github":null,"linkedin":"https://www.linkedin.com/company/indiebio/","contact_email":null,"added_at":"2026-09-04T03:50:13.532Z","added_via":"web","geo":{"keywords":["Accelerator","Startup accelerator","Biotech","Life Sciences","Synthetic Biology","Diagnostics","Deep Tech"],"canonical_facts":["Run by SOSV","Funding offer: Pre-seed investment (amount varies per company)","Cohorts: multiple cohorts per year"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-04T03:50:13.532Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"accelerator","name":"Accelerator","note":null,"profile_url":"/industries/accelerator"},{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"deep-tech","name":"Deep Tech","note":null,"profile_url":"/industries/deep-tech"},{"kind":"industry","slug":"diagnostics","name":"Diagnostics","note":null,"profile_url":"/industries/diagnostics"},{"kind":"industry","slug":"life-sciences","name":"Life Sciences","note":null,"profile_url":"/industries/life-sciences"},{"kind":"industry","slug":"synthetic-biology","name":"Synthetic Biology","note":null,"profile_url":"/industries/synthetic-biology"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-04T03:50:13.532Z","updated_at":"2026-09-04T03:50:13.532Z"}}],"total":33,"limit":50,"offset":0}